(Q52868900)
Statements
Interim report of a randomized trial comparing Zoladex 3.6 mg depot with diethylstilbestrol 3 mg/day in advanced prostate cancer. The West Midlands Urology Research Group. (English)
Emtage LA
Trethowan C
Hilton C
Kelly K
Blackledge GR
1 January 1988
11 Suppl 2
S173-5